Brief Company Profile
◆ Founded in 2005, Breakeven in 2009, Listed in NEEQ (National Equities Exchange and Quotations, code: 831186) in 2014.
◆ Previously an International Trading and Distribution company. (Import and Distribute Olbetam? from Pfizer in 1999).
◆ 4 Factories: F1-Cephalosporins for Injection, F2-Cephalosporins for Oral, F3-Other Chemical Product for Oral ( e.g. Loxoprofen Soft capsule), F4-TCM for Oral.
◆ Total employees country-wide: 768 (443 sales-men).
◆ Research Lab – Specialized in Cephalosporin (Oral disintegrating methods, Fruit Flavoring, etc.), very strong abilities on gaining approvals from CFDA, funded by 10% of annual company profit.
◆ Marketing Dpt. – Academic conference member recognized by the government, new release product in the Procurement directory.
◆ Sales Dpt. – Country-wide covered by on field local sales men, office in every Province of China. Specifically strong relationship with Tertiary Hospital and Local Health Centers.
◆ 99% of our sales paid by Cash.
Newly purchase 53450 m2 of industrial land in Zhuhai for company expansion.
◆ Expanding sales group all over the country for new release product.
◆ Sourcing Business Development opportunities through company’s Excess funds.
Inspection – NDA, Uganda
Inspection – FMHACA, Ethiopia
Inspection - NAFDAC
Inspection - DPM Cote d’Ivoire
Powder for Injection Workshop
Oral Preparation Workshop
Powder for Injection
Corridor – Powder
for Injection workshop
Oral products workshop
Products: Dry Suspension, Granules, Chewable Tablets, Oral Dispersible Tablets
Hard gelatin capsules, Soft gelatin capsules & tablets
QC department has specified area for Physical, chemical and microbial tests.
Equipped with HPLC, GC, IR Spectrometer and UV Spectrometer, etc for all the tests and analysis.
R & D Department
Activities: Regulatory affairs of registration, pilot research and production for formulation and API, etc.